about
SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infectionEmergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciHigh-Resolution Crystal Structure of the Subclass B3 Metallo- -Lactamase BJP-1: Rational Basis for Substrate Specificity and Interaction with SulfonamidesDesign, Synthesis, and Crystal Structures of 6-Alkylidene-2′-Substituted Penicillanic Acid Sulfones as Potent Inhibitors of Acinetobacter baumannii OXA-24 CarbapenemaseAcinetobacter baumanniiFolD ligand complexes - potent inhibitors of folate metabolism and a re-evaluation of the structure of LY374571Evolution to carbapenem-hydrolyzing activity in noncarbapenemase class D -lactamase OXA-10 by rational protein designStructure Guided Development of Novel Thymidine Mimetics Targeting Pseudomonas aeruginosa Thymidylate Kinase: From Hit to Lead GenerationCatalysis and Sulfa Drug Resistance in Dihydropteroate SynthaseBiomaterials and Nanotherapeutics for Enhancing Skin Wound HealingSelection of resistant bacteria at very low antibiotic concentrationsAn overview of antimicrobial resistance and its public health significance.Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.High-frequency transposition for determining antibacterial mode of action.High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural VietnamPolicy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS).Antibiotic-resistant Escherichia coli bacteria, including strains with genes encoding the extended-spectrum beta-lactamase and QnrS, in waterbirds on the Baltic Sea Coast of PolandAntibacterial activities of Beilschmiedia obscura and six other Cameroonian medicinal plants against multi-drug resistant Gram-negative phenotypesCorrelations between Income inequality and antimicrobial resistance.Functional characterization of two defensin isoforms of the hard tick Ixodes ricinus.Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.Plasmid-Mediated Antibiotic Resistance and Virulence in Gram-negatives: the Klebsiella pneumoniae Paradigm.Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogensAntibiotic resistance is widespread in urban aquatic environments of Rio de Janeiro, Brazil.Development and validation of a high-throughput cell-based screen to identify activators of a bacterial two-component signal transduction system.Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR).Effects of dietary Lactobacillus plantarum and AHL lactonase on the control of Aeromonas hydrophila infection in tilapia.Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.Combination therapy for treatment of infections with gram-negative bacteria.Enterobacteriaceae Isolated from the River Danube: Antibiotic Resistances, with a Focus on the Presence of ESBL and Carbapenemases.Acyl-sulfamates target the essential glycerol-phosphate acyltransferase (PlsY) in Gram-positive bacteria.Antibacterial and antibiotic resistance modulatory activities of leaves and bark extracts of Recinodindron heudelotii (Euphorbiaceae) against multidrug-resistant Gram-negative bacteria.Silver nanoparticles: Antimicrobial activity, cytotoxicity, and synergism with N-acetyl cysteine.Combined biomarkers discriminate a low likelihood of bacterial infection among surgical intensive care unit patients with suspected sepsis.Type IV traffic ATPase TrwD as molecular target to inhibit bacterial conjugation.The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock.Antimicrobial resistance patterns and integron carriage of Escherichia coli isolates causing community-acquired infections in Turkey.Clinical outcomes of extended versus intermittent administration of piperacillin/tazobactam for the treatment of hospital-acquired pneumonia: a randomized controlled trial.Management of antibiotic resistance in the intensive care unit setting.Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains.
P2860
Q24336522-66D72439-3EC1-4BA3-962D-C012ECEF667CQ24617818-B491EEBC-51C2-4495-81AB-C8A5B0B51B4FQ26853465-98E4994C-0D00-406F-BD0D-CD6D4EC0E0F9Q27664009-31B6FD01-9472-4D44-A6B1-33C08361F529Q27664292-2CD437DA-1985-4914-B7E4-4DCDDD832BFEQ27674388-0B2434D0-77D9-424E-AE9C-BF4843377AC3Q27675331-CA563CD9-3502-4BFF-A49A-EBB3B7C56605Q27676722-217B2C04-E377-4211-9689-AC3C0268F091Q27677575-2D7E0AEE-7D13-4A71-8791-0340E7DF0E28Q28077978-00BEB997-01BC-439A-8317-B001FF7362A7Q28479239-81A9B4DA-1753-4F00-A482-B5C1FF3B15A4Q33761875-41E78E31-C87A-44EC-A4BD-5D14E9146D5AQ33940174-33F8CD7C-476E-4E1F-B261-B1E2DF1E7171Q34011008-A96B7104-212C-4386-AF72-180D702BCB9CQ34237433-856A0227-7097-4618-B12E-7D14FD527996Q34261329-15FC0D9A-0EB7-4A0F-9AF1-F1341B9F2120Q34432199-0073FB34-63C3-4CAE-B198-D4CF0DFCEBCEQ34469591-2F54D666-EADA-4D81-A2E4-66E74781526AQ34979717-891689C5-2659-48CD-8946-3F3384F14B45Q35009172-398A86BE-F9A4-4496-B507-E0FA7A4C2DC7Q35014136-8E96CD22-AB49-4A10-87F4-40290D0339CDQ35104348-A36F0C65-7B98-490A-9499-E7480FE123B5Q35131669-F27EF5A2-8180-41C4-B8CE-13A0DD8448D3Q35167556-4DB116F2-FE41-4243-B73F-8B23D7BDF3D8Q35600598-4DCA8C6F-A2FE-4BF7-A364-68F13E10FA82Q35975462-F7B5DD67-024C-4760-A7CB-078C4B98F7F3Q35995166-F89B7CB8-A2A3-4996-A7BF-E6FA95331536Q36075949-33CCAF27-B0E1-4266-BDB6-699978FA6D75Q36156077-7F7A0E8A-838C-48FC-A1BF-905BA9BA0E08Q36182215-24371D5A-5166-461F-BB73-C10B49D64F7AQ36319087-E9433185-0B40-4150-BB13-8796895F7FF1Q36322582-8A9C7A7C-5D80-4413-8DC7-70F8A9B849E7Q36381233-9926A12B-4EC2-4FE8-B596-F9A9E88A0773Q36827369-57ACEBDF-D393-4893-904E-91CE4E9618B0Q37006822-CF7B9C57-5F6E-4BFF-8C05-3107E89E43F0Q37563005-DA38B913-F623-429C-B162-24B454E0C7FEQ37628831-170860CB-202C-47D4-AD6A-7DDD12021830Q37642084-79583768-BECA-4616-95EC-D9EC06100563Q37700552-EB888E54-868E-4817-B5A3-322023CC7ECBQ37707919-BAD989C7-DF1B-41A6-8A10-A08B5FAF3B3B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The clinical consequences of antimicrobial resistance.
@en
The clinical consequences of antimicrobial resistance.
@nl
type
label
The clinical consequences of antimicrobial resistance.
@en
The clinical consequences of antimicrobial resistance.
@nl
prefLabel
The clinical consequences of antimicrobial resistance.
@en
The clinical consequences of antimicrobial resistance.
@nl
P1476
The clinical consequences of antimicrobial resistance.
@en
P2093
Louis B Rice
P304
P356
10.1016/J.MIB.2009.08.001
P577
2009-08-27T00:00:00Z